CR11541A - Derivado de 17-(1 -propenil)-17-3 -oxidoestra-4-en-3-ona, su uso y medicamentos que lo contienen - Google Patents

Derivado de 17-(1 -propenil)-17-3 -oxidoestra-4-en-3-ona, su uso y medicamentos que lo contienen

Info

Publication number
CR11541A
CR11541A CR11541A CR11541A CR11541A CR 11541 A CR11541 A CR 11541A CR 11541 A CR11541 A CR 11541A CR 11541 A CR11541 A CR 11541A CR 11541 A CR11541 A CR 11541A
Authority
CR
Costa Rica
Prior art keywords
oxidoestra
propenil
ona
derived
medications containing
Prior art date
Application number
CR11541A
Other languages
English (en)
Inventor
Klar Ulrich
Kuhnke Joachim
Hubner Jam
Ring Sven
Frenzel Thomas
Menges Frederik
Muhn Hans-Peter
Prelle Katja
Bohlmann Rolf
Borden Stefen
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40679349&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR11541(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CR11541A publication Critical patent/CR11541A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

La invencion se refiere a derivados de 17-(1 -propenil9-17-3 -oxidoestra-4-en-3ona que tienen la formula quimica general I, en la cual Z, R6a, R6b, R7, R15, R16a, R16b y R18 tienen los valores que se indican en la reivindicacion 1, asi como sus solvatos, hidratos y sales, incluyendo todos los estereoisomeros de estos compuestos.
CR11541A 2007-12-29 2010-06-29 Derivado de 17-(1 -propenil)-17-3 -oxidoestra-4-en-3-ona, su uso y medicamentos que lo contienen CR11541A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007063500A DE102007063500A1 (de) 2007-12-29 2007-12-29 17-(1'-Propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CR11541A true CR11541A (es) 2010-08-05

Family

ID=40679349

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11541A CR11541A (es) 2007-12-29 2010-06-29 Derivado de 17-(1 -propenil)-17-3 -oxidoestra-4-en-3-ona, su uso y medicamentos que lo contienen

Country Status (23)

Country Link
US (1) US9034856B2 (es)
EP (1) EP2238147B1 (es)
JP (1) JP5600069B2 (es)
KR (1) KR20100102190A (es)
CN (1) CN101918426A (es)
AR (1) AR069964A1 (es)
AU (1) AU2008342912A1 (es)
BR (1) BRPI0822068A2 (es)
CA (1) CA2710934C (es)
CL (1) CL2008003885A1 (es)
CR (1) CR11541A (es)
DE (1) DE102007063500A1 (es)
DO (1) DOP2010000201A (es)
EC (1) ECSP10010316A (es)
ES (1) ES2397985T3 (es)
IL (1) IL206381A0 (es)
MX (1) MX2010007269A (es)
PA (1) PA8807901A1 (es)
PE (1) PE20091185A1 (es)
TW (1) TW200940562A (es)
UY (1) UY31582A1 (es)
WO (1) WO2009083268A2 (es)
ZA (1) ZA201005397B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012059594A1 (en) 2010-11-04 2012-05-10 Bayer Pharma Aktiengesellschaft Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1183500B (de) 1962-10-12 1964-12-17 Schering Ag Verfahren zur Herstellung von alpha, beta-Methylenketonen der Steroidreihe
CH559220A5 (es) * 1970-03-06 1975-02-28 Ciba Geigy Ag
US3705179A (en) 1971-03-15 1972-12-05 American Home Prod Antiandrogenic steroids
US3764596A (en) * 1971-06-22 1973-10-09 Sandoz Ag 17-dihydrofuranyl-substituted steroids
NL7701384A (nl) 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE2922500A1 (de) 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta
DE3402329A1 (de) 1984-01-20 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen 6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
FR2598421B1 (fr) * 1986-05-06 1988-08-19 Roussel Uclaf Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
DE3702383A1 (de) * 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4232521A1 (de) * 1992-09-22 1994-03-24 Schering Ag Gestagen wirksame 4,5;11,12-Estradiene, Verfahren zu ihrer Herstellung, diese Estradiene enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln
DE19651000A1 (de) 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
DE102004063864A1 (de) 2004-12-30 2006-07-13 Schering Ag 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
EP2238147B1 (de) 2012-10-24
ZA201005397B (en) 2012-01-25
EP2238147A2 (de) 2010-10-13
AU2008342912A1 (en) 2009-07-09
KR20100102190A (ko) 2010-09-20
DOP2010000201A (es) 2010-07-15
CL2008003885A1 (es) 2010-05-07
WO2009083268A2 (de) 2009-07-09
TW200940562A (en) 2009-10-01
UY31582A1 (es) 2009-08-03
US9034856B2 (en) 2015-05-19
MX2010007269A (es) 2010-10-15
JP2011507925A (ja) 2011-03-10
JP5600069B2 (ja) 2014-10-01
US20100317632A1 (en) 2010-12-16
AR069964A1 (es) 2010-03-03
CA2710934A1 (en) 2009-07-09
WO2009083268A3 (de) 2009-09-24
DE102007063500A1 (de) 2009-07-02
BRPI0822068A2 (pt) 2015-06-23
CN101918426A (zh) 2010-12-15
ES2397985T3 (es) 2013-03-12
ECSP10010316A (es) 2010-08-31
IL206381A0 (en) 2010-12-30
CA2710934C (en) 2015-07-21
PE20091185A1 (es) 2009-09-06
PA8807901A1 (es) 2009-07-23

Similar Documents

Publication Publication Date Title
CY1121899T1 (el) Βοριουχα μικρομορια ως αντιφλεγμονωδεις παραγοντες
CO6220968A2 (es) Inhibidores heterociclicos de la aspartil proteasa
AR110056A2 (es) Modulación de receptores quimiosensoriales y ligandos relacionados con los mismos
MX2009007077A (es) Analogos de ciclopamina.
UY31145A1 (es) Derivado de 17b+ciano-18a-homo-19-nor-androst-4-eno, su uso y medicamento que lo contiene
DOP2010000046A (es) Compuestos de biciclolactama sustituida
SV2011003809A (es) Derivados de heteroarilo como inhibidores de dgat1
BRPI0806689A2 (pt) Compostos químicos 637
ECSP10010722A (es) Compuestos orgánicos
EA201101060A1 (ru) Новые гербициды
EA201101148A1 (ru) Новые гербициды
EA201000272A1 (ru) Трициклические мостиковые производные циклопентадиенона, как гербициды
BRPI0914450A2 (pt) "equipamento de estrumental círurgico"
CR8879A (es) Bifeniltiazolcarboxamidas
BRPI0917815A2 (pt) Combinação herbicida que contém difluormetano sulfonilanilidas substituídas por dimetoxitriazilina
BRPI1015043A2 (pt) derivados de diazahomoadamantano e métodos de uso dos mesmos
EA201101146A1 (ru) Новые гербициды
CR11098A (es) Compuestos de pirido [2,3-d] pirimidina-7-ona como inhibidores de p13k-alfa para el tratamiento del cancer
EA201101097A1 (ru) Новые микробиоциды
CL2007002388A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de hemangiomas o hemangioblastomas.
UY31146A1 (es) Derivado de 17b-ciano-19-nor-androst-4-eno, su uso y medicamento que lo contiene
CR11541A (es) Derivado de 17-(1 -propenil)-17-3 -oxidoestra-4-en-3-ona, su uso y medicamentos que lo contienen
UY29996A1 (es) Uso de gibberellina como asegurador para azoles para combatir hongos nocivos.
CR11544A (es) Derivado 15,16-metilen-17-(1'-propenil)-17-3'-oxidoestra-4-3-ona, su uso y medicamento que lo contiene
CR11545A (es) Derivado de y-lactona del esteroide del acido 17-hidroxi-19-nor-21-carboxilico su uso y el medicamento que lo contiene

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)